{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:00Z","timestamp":1792081500533,"version":"4.4.0"},"reference-count":61,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":280,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13-00096"],"award-info":[{"award-number":["PI13-00096"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Endocrine Society \/ Genentech, Inc","award":["Endocrine Scholar Award in Growth Hormone Research"],"award-info":[{"award-number":["Endocrine Scholar Award in Growth Hormone Research"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX001114"],"award-info":[{"award-number":["BX001114"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State of Ohio's Eminent Scholar Program","award":["Includes a gift by Milton and Lawrence Goll"],"award-info":[{"award-number":["Includes a gift by Milton and Lawrence Goll"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG031736"],"award-info":[{"award-number":["P01AG031736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK088133"],"award-info":[{"award-number":["R01DK088133"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24DK76174"],"award-info":[{"award-number":["U24DK76174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:p>Patients with nonalcoholic fatty liver disease (NAFLD) are reported to have low growth hormone (GH) production and\/or hepatic GH resistance. GH replacement can resolve the fatty liver condition in diet-induced obese rodents and in GH-deficient patients. However, it remains to be determined whether this inhibitory action of GH is due to direct regulation of hepatic lipid metabolism. Therefore, an adult-onset, hepatocyte-specific, GH receptor (GHR) knockdown (aLivGHRkd) mouse was developed to model hepatic GH resistance in humans that may occur after sexual maturation. Just 7 days after aLivGHRkd, hepatic de novo lipogenesis (DNL) was increased in male and female chow-fed mice, compared with GHR-intact littermate controls. However, hepatosteatosis developed only in male and ovariectomized female aLivGHRkd mice. The increase in DNL observed in aLivGHRkd mice was not associated with hyperactivation of the pathway by which insulin is classically considered to regulate DNL. However, glucokinase mRNA and protein levels as well as fructose-2,6-bisphosphate levels were increased in aLivGHRkd mice, suggesting that enhanced glycolysis drives DNL in the GH-resistant liver. These results demonstrate that hepatic GH actions normally serve to inhibit DNL, where loss of this inhibitory signal may explain, in part, the inappropriate increase in hepatic DNL observed in NAFLD patients.<\/jats:p>","DOI":"10.2337\/db15-0370","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T12:36:22Z","timestamp":1432730182000},"page":"3093-3103","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":102,"title":["Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice"],"prefix":"10.2337","volume":"64","author":[{"given":"Jose","family":"Cordoba-Chacon","sequence":"first","affiliation":[{"name":"Research and Development Division, Jesse Brown VA Medical Center, Chicago, IL"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Research and Development Division, Jesse Brown VA Medical Center, Chicago, IL"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward O.","family":"List","sequence":"additional","affiliation":[{"name":"Edison Biotechnology Institute, Ohio University, Athens, OH"},{"name":"Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Diaz-Ruiz","sequence":"additional","affiliation":[{"name":"Experimental Gerontology Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Frank","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL"},{"name":"Endocrinology Section Medical Service, Birmingham VA Medical Center, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Manzano","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, University of Barcelona, L'Hospitalet, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Bartrons","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, University of Barcelona, L'Hospitalet, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Puchowicz","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Kopchick","sequence":"additional","affiliation":[{"name":"Edison Biotechnology Institute, Ohio University, Athens, OH"},{"name":"Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda D.","family":"Kineman","sequence":"additional","affiliation":[{"name":"Research and Development Division, Jesse Brown VA Medical Center, Chicago, IL"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"2022031300374825200_B1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2015.01.001","article-title":"A concise review of non-alcoholic fatty liver disease","volume":"239","author":"Than","year":"2015","journal-title":"Atherosclerosis"},{"key":"2022031300374825200_B2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CCO.0000000000000042","article-title":"Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer","volume":"26","author":"Lade","year":"2014","journal-title":"Curr Opin Oncol"},{"key":"2022031300374825200_B3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2022031300374825200_B4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2014.08.001","article-title":"Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD","volume":"25","author":"Fuchs","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"2022031300374825200_B5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"2022031300374825200_B6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr Physiol"},{"key":"2022031300374825200_B7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes Metab"},{"key":"2022031300374825200_B8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"2022031300374825200_B9","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s00125-009-1405-9","article-title":"Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes","volume":"52","author":"Wilke","year":"2009","journal-title":"Diabetologia"},{"key":"2022031300374825200_B10","first-page":"739","article-title":"Clinical relevance of systemic and local IGF-I: lessons from animal models","volume":"5","author":"LeRoith","year":"2008","journal-title":"Pediatr Endocrinol Rev"},{"key":"2022031300374825200_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2009.09.002","article-title":"Biological effects of growth hormone on carbohydrate and lipid metabolism","volume":"20","author":"Vijayakumar","year":"2010","journal-title":"Growth Horm IGF Res"},{"key":"2022031300374825200_B12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300374825200_B13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ijo.0800807","article-title":"Growth hormone in obesity","volume":"23","author":"Scacchi","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2022031300374825200_B14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/jc.2002-021308","article-title":"Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition","volume":"89","author":"De Marinis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300374825200_B15","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2022031300374825200_B16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2022031300374825200_B17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-12-0002","article-title":"Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study","volume":"166","author":"Gardner","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2022031300374825200_B18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1530\/EC-14-0078","article-title":"Liver status in congenital, untreated, isolated GH deficiency","volume":"3","author":"Diniz","year":"2014","journal-title":"Endocr Connect"},{"key":"2022031300374825200_B19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ghir.2008.03.003","article-title":"Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion\u2014preliminary report","volume":"18","author":"Laron","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"2022031300374825200_B20","doi-asserted-by":"crossref","first-page":"e44136","DOI":"10.1371\/journal.pone.0044136","article-title":"Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"key":"2022031300374825200_B21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11695-007-9087-1","article-title":"IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients","volume":"17","author":"Garc\u00eda-Galiano","year":"2007","journal-title":"Obes Surg"},{"key":"2022031300374825200_B22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12072-007-9007-4","article-title":"Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease","volume":"1","author":"Ichikawa","year":"2007","journal-title":"Hepatol Int"},{"key":"2022031300374825200_B23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jgh.12437","article-title":"Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States","volume":"29","author":"Runchey","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"2022031300374825200_B24","article-title":"Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease","author":"Sumida","year":"2014","journal-title":"Hepatol Res"},{"key":"2022031300374825200_B25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-0374","article-title":"Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample","volume":"161","author":"V\u00f6lzke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2022031300374825200_B26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.diabet.2014.02.008","article-title":"Regulation of growth hormone induced JAK2 and mTOR signalling by hepatic protein tyrosine phosphatase 1B","volume":"41","author":"Owen","year":"2015","journal-title":"Diabetes Metab"},{"key":"2022031300374825200_B27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tem.2012.01.001","article-title":"Mapping the growth hormone\u2014Stat5b\u2014IGF-I transcriptional circuit","volume":"23","author":"Rotwein","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"2022031300374825200_B28","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/en.2010-1423","article-title":"Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats","volume":"152","author":"Bielohuby","year":"2011","journal-title":"Endocrinology"},{"key":"2022031300374825200_B29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","article-title":"Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation","volume":"8","author":"Dong","year":"2008","journal-title":"Cell Metab"},{"key":"2022031300374825200_B30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/jc.2011-2681","article-title":"Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial","volume":"97","author":"Madsen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300374825200_B31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/en.2014-1617","article-title":"Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet","volume":"156","author":"Yang","year":"2015","journal-title":"Endocrinology"},{"key":"2022031300374825200_B32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1476-511X-9-78","article-title":"Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats","volume":"9","author":"Qin","year":"2010","journal-title":"Lipids Health Dis"},{"key":"2022031300374825200_B33","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00125-009-1402-z","article-title":"Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes","volume":"52","author":"List","year":"2009","journal-title":"Diabetologia"},{"key":"2022031300374825200_B34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/me.2012-1330","article-title":"The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice","volume":"27","author":"List","year":"2013","journal-title":"Mol Endocrinol"},{"key":"2022031300374825200_B35","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1152\/ajpendo.00420.2014","article-title":"Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice","volume":"307","author":"Cordoba-Chacon","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031300374825200_B36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1432-1033.1982.tb07039.x","article-title":"A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate","volume":"129","author":"Van Schaftingen","year":"1982","journal-title":"Eur J Biochem"},{"key":"2022031300374825200_B37","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1074\/jbc.M808668200","article-title":"Triglyceride synthesis in epididymal adipose tissue: contribution of glucose and non-glucose carbon sources","volume":"284","author":"Bederman","year":"2009","journal-title":"J Biol Chem"},{"key":"2022031300374825200_B38","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3945\/jn.109.113092","article-title":"Reduced milk triglycerides in mice lacking phosphoenolpyruvate carboxykinase in mammary gland adipocytes and white adipose tissue contribute to the development of insulin resistance in pups","volume":"139","author":"Hsieh","year":"2009","journal-title":"J Nutr"},{"key":"2022031300374825200_B39","doi-asserted-by":"crossref","first-page":"E917","DOI":"10.1152\/ajpendo.00128.2003","article-title":"Influence of diet on the modeling of adipose tissue triglycerides during growth","volume":"285","author":"Brunengraber","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031300374825200_B40","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1359\/JBMR.050811","article-title":"Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis","volume":"20","author":"Venken","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2022031300374825200_B41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"Ann Hepatol"},{"key":"2022031300374825200_B42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"2022031300374825200_B43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cmet.2011.08.005","article-title":"Estrogen receptors and the metabolic network","volume":"14","author":"Barros","year":"2011","journal-title":"Cell Metab"},{"key":"2022031300374825200_B44","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1074\/jbc.M109.014308","article-title":"Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism","volume":"284","author":"Fan","year":"2009","journal-title":"J Biol Chem"},{"key":"2022031300374825200_B45","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1172\/JCI42894","article-title":"Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2","volume":"121","author":"Sos","year":"2011","journal-title":"J Clin Invest"},{"key":"2022031300374825200_B46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"key":"2022031300374825200_B47","first-page":"241","article-title":"Sex-specific differences in lipid and glucose metabolism","volume":"5","author":"Varlamov","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022031300374825200_B48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcn\/87.4.817","article-title":"Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding","volume":"87","author":"Chong","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"2022031300374825200_B49","doi-asserted-by":"crossref","first-page":"37098","DOI":"10.1074\/jbc.M112.339887","article-title":"Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation","volume":"287","author":"Kim","year":"2012","journal-title":"J Biol Chem"},{"key":"2022031300374825200_B50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0968-0004(00)01699-6","article-title":"PFK-2\/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate","volume":"26","author":"Okar","year":"2001","journal-title":"Trends Biochem Sci"},{"key":"2022031300374825200_B51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/en.2010-0537","article-title":"GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism","volume":"152","author":"Barclay","year":"2011","journal-title":"Endocrinology"},{"key":"2022031300374825200_B52","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep.21713","article-title":"Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration","volume":"46","author":"Cui","year":"2007","journal-title":"Hepatology"},{"key":"2022031300374825200_B53","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.24509","article-title":"Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice","volume":"54","author":"Mueller","year":"2011","journal-title":"Hepatology"},{"key":"2022031300374825200_B54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1172\/JCI200417763","article-title":"Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice","volume":"113","author":"Yakar","year":"2004","journal-title":"J Clin Invest"},{"key":"2022031300374825200_B55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jhep.2013.03.037","article-title":"Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy","volume":"59","author":"Xu","year":"2013","journal-title":"J Hepatol"},{"key":"2022031300374825200_B56","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1210\/en.2013-2086","article-title":"Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles","volume":"155","author":"List","year":"2014","journal-title":"Endocrinology"},{"key":"2022031300374825200_B57","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11883-004-0030-9","article-title":"Antidiabetic actions of estrogen: insight from human and genetic mouse models","volume":"6","author":"Louet","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"2022031300374825200_B58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0083-6729(08)00606-7","article-title":"Crosstalk between growth hormone and insulin signaling","volume":"80","author":"Xu","year":"2009","journal-title":"Vitam Horm"},{"key":"2022031300374825200_B59","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1194\/jlr.M700090-JLR200","article-title":"Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver","volume":"48","author":"Morral","year":"2007","journal-title":"J Lipid Res"},{"key":"2022031300374825200_B60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1476-5381.2012.02184.x","article-title":"Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans","volume":"168","author":"De Ceuninck","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2022031300374825200_B61","doi-asserted-by":"crossref","first-page":"E1126","DOI":"10.1210\/jc.2010-2017","article-title":"Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans","volume":"96","author":"Peter","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/64\/9\/3093\/580175\/db150370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/64\/9\/3093\/580175\/db150370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:46:49Z","timestamp":1667393209000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/64\/9\/3093\/34807\/Growth-Hormone-Inhibits-Hepatic-De-Novo"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,5,26]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db15-0370","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}